SLC4A1 and COVID-19: Furthermore, RBCs of COVID-19 patients contain increased levels of glycolytic intermediates, accompanied by oxidation and fragmentation of ankyrin, β-spectrin, and the N-terminal cytosolic domain of Band 3 (AE1).